Skip to main content
Premium Trial:

Request an Annual Quote

Research Instruments of Singapore to Distribute Genomatix Regionally

This article has been updated to correct the spelling of Genomatix's name.


NEW YORK, March 6 (GenomeWeb News) - Singapore-based Research Instruments will distribute Genomatix Software's product line in Singapore and Thailand, the companies announced today.


Singapore General Hospital will be one of the recipients, according to a release.


SGH will apply the Genomatix chip-analysis pipeline to its Affymetrix-based expression studies.


Financial details were not provided.


Genomatix, based in Munich, Germany, specializes in microarray and eukaryotic gene analysis.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.